Comparison Between the HYPERSCINT RP200 Scintillation Detector and Other Small Field Detectors for 10MV FFF SRS Beam Modelling On a VersaHD Linear Accelerator

Plastic scintillation detectors (PSDs) have advantageous dosimetric properties, including small size and energy independence, which make them ideal candidates for small field dosimetry.

2021 AAPM AM
J.Morin, JF.Cabana, M.Goulet, D.Theriault | CISSS – Chaudiere-Appalaches, Lévis, QC, CA

Technical note: Characterization and practical applications of a novel plastic scintillator for online dosimetry for an ultrahigh dose rate (FLASH)

Although flash radiation therapy (FLASH-RT) is a promising novel technique that has the potential to achieve a better therapeutic ratio between tumor control and normal tissue complications, the ultrahigh pulsed dose rates (UHPDR) mean that experimental dosimetry is very challenging.

Med Phys. 2022
Y.Poirier (1,2), J.Xu (1), S.Mossahebi (1), F.Therriault-Proulx (3), A.Sawant (1) | Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland, USA, Department of Medical Physics, McGill University, Montreal, Quebec, Canada, MedScint, QC, CA

Patient Specific QA for External Beam Radiotherapy Using the HYPERSCINT Plastic Scintillation Detector

Plastic scintillation detectors (PSDs) have interesting dosimetric properties, including small size and energy independence. These advantages make them well suited for VMAT patient-specific QA, either alone or in conjunction with a detector matrix. This work aims to determine if the HYPERSCINT scintillation dosimetry research platform (Medscint inc., Quebec city, Canada) can replace the classic ion chamber in a clinical patient-specific QA workflow.

2020 AAPM AM
M.Goulet | CISSS – Chaudiere-Appalaches, Lévis, QC, CA

Brachytherapy Technique Commissioning Using the HYPERSCINT Plastic Scintillation Detector

Accurate dosimetry in brachytherapy is not an easy task, as most detectors exhibit volume averaging or energy dependance reducing their usability. Free from these limitations are plastic scintillation detectors (PSDs), which makes them well suited for brachytherapy applications, either for in vivo dosimetry or commissioning. This work aims to determine if the HYPERSCINT scintillation dosimetry research platform (Medscint inc., Quebec city, Canada) can be used for brachytherapy dose measurement in the context of commissioning a new brachytherapy technique.

2020 AAPM AM
M.Goulet, N.Octave, P.Duguay-drouin | CISSS – Chaudiere-Appalaches, Lévis, QC, CA

Dosimetric Characterization of the ARIEL 10 MV X-Ray Ultrahigh Dose-Rate (FLASH) Irradiation Platform at TRIUMF

To characterize the beam delivery capabilities and dose rates achievable on the new ultrahigh dose-rate (UHDR) 10MV x-ray irradiation platform at TRIUMF.

2022 AAPM AM
N.Esplen (1), L.Egoriti (2), T.Planche (3), A.Hart (1), B.Paley (3), C.Hoehr (3), A.Gottberg (3), M.Bazalova-Carter (1) | University of Victoria, Victoria, BC ,CA (1), University of British Columbia, BC, CA (2), TRIUMF, Vancouver, BC, CA (3)

On the Use of a Commercial Plastic Scintillation Detector for Determination of Detector-Specific Small Field Output Correction Factors of Other Detectors

The goal of this work is to determine small field output correction factors of various detectors using a commercial plastic scintillation detector as a reference and to compare values with current available data.

2022 AAPM AM
M.Besnier (1), F.Beaulieu (1), F.Berthiaume (1,2), Y.Cervantes Espinosa (1), B.Côté (2), S.Lambert-girard (1,2), D.Leblanc (1,2), Y.Lechasseur (2), F.Therriault-Proulx (2), L.Archambault (1), L.Beaulieu (1), L.Gingras (1) | CHU de Quebec – Universite Laval, QC, CA, MedScint, QC, CA

Comparative optic and dosimetric characterization of the HYPERSCINT scintillation dosimetry research platform for multipoint applications

This study introduces the HYPERSCINT research platform (HYPERSCINT-RP100, Medscint Inc., Quebec, Canada), the first commercially available scintillation dosimetry platform capable of multi-point dosimetry through the hyperspectral approach.

Phys Med Biol. 2021
E.Jean (1,2,3), F.Therriault-Proulx (4), L.Beaulieu (1,2) | Département de physique, génie physique et optique, et Centre de recherche sur le cancer, Université Laval, Québec, CA , Département de radio-oncologie et Axe Oncologie du CRCHU de Québec, QC, CA, Département de radio-oncologie du CIUSSS-MCQ, CHAUR de Trois-Rivières, Trois-Rivières, QC, Canada, MedScint, QC, CA